BONE TURNOVER IN SICKLE CELL DISEASE
BONE TURNOVER IN SICKLE CELL DISEASE
批准号:
7375148
负责人:
John David Roberts
金额:
$0.06万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. It is proposed that an increase in bone turnover may play a role in bone pain and development of sickle cell crisis. Therefore this protocol will measure bone metabolism via quantification of serum bone specific alkaline phosphatase and N-telopeptide. The aim is to investigate whether increased bone turnover is temporally related to sickle cell crisis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:8166535
-
项目类别:
-
资助金额:$2.24万
-
财政年份:2009
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: PILOT/PHASE 1 STUDY OF ZOLEDRONIC ACID (ZOMETA ) IN SICKLE CELL
-
批准号:7950882
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2008
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:7950860
-
项目类别:
-
资助金额:$3.22万
-
财政年份:2008
-
负责人:John David Roberts
-
依托单位:
Clinical Protocol and Data Management
-
批准号:7698841
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2008
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: NCI 6858: A PHASE 1 STUDY OF SUBEROYLANILIDE HYDROXAMIC ACID (S
-
批准号:7950875
-
项目类别:
-
资助金额:$2.43万
-
财政年份:2008
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: A PHASE 2 STUDY OF AZD6244 IN ADVANCED OR METASTATIC HEPATOCELLU
-
批准号:7950892
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2008
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: NCI 6858: A PHASE 1 STUDY OF SUBEROYLANILIDE HYDROXAMIC ACID (S
-
批准号:7717049
-
项目类别:
-
资助金额:$0.91万
-
财政年份:2007
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:7717028
-
项目类别:
-
资助金额:$0.38万
-
财政年份:2007
-
负责人:John David Roberts
-
依托单位:
COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:7605017
-
项目类别:
-
资助金额:$1.47万
-
财政年份:2006
-
负责人:John David Roberts
-
依托单位:
NCI 6858: A PHASE 1 STUDY OF SUBEROYLANILIDE HYDROXAMIC ACID (SAHA) IN COMBI
-
批准号:7605042
-
项目类别:
-
资助金额:$1.9万
-
财政年份:2006
-
负责人:John David Roberts
-
依托单位:
BONE TURNOVER IN SICKLE CELL DISEASE
-
批准号:7605010
-
项目类别:
-
资助金额:$0.56万
-
财政年份:2006
-
负责人:John David Roberts
-
依托单位:
COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:7375157
-
项目类别:
-
资助金额:$3.29万
-
财政年份:2005
-
负责人:John David Roberts
-
依托单位:
COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:7201520
-
项目类别:
-
资助金额:$0.04万
-
财政年份:2004
-
负责人:John David Roberts
-
依托单位:
Modulation of the Bio. Response to IL-2 with Bryostatin
-
批准号:7040921
-
项目类别:
-
资助金额:$4.33万
-
财政年份:2003
-
负责人:John David Roberts
-
依托单位:
CORE--CLINICAL PROTOCOL AND DATA MANAGEMENT
-
批准号:6592801
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2002
-
负责人:John David Roberts
-
依托单位:
PHASE 1 TRIAL OF BRYOSTATIN AND INTERLEUKIN-2
-
批准号:6087104
-
项目类别:
-
资助金额:$14.18万
-
财政年份:2000
-
负责人:John David Roberts
-
依托单位:
VCU MINORITY-BASED CCOP
-
批准号:6375883
-
项目类别:
-
资助金额:$45.93万
-
财政年份:2000
-
负责人:John David Roberts
-
依托单位:
VCU MINORITY-BASED CCOP
-
批准号:6754374
-
项目类别:
-
资助金额:$46.31万
-
财政年份:2000
-
负责人:John David Roberts
-
依托单位:
VCU MINORITY-BASED CCOP
-
批准号:6633035
-
项目类别:
-
资助金额:$42.93万
-
财政年份:2000
-
负责人:John David Roberts
-
依托单位:
CORE--CLINICAL RESEARCH
-
批准号:6300072
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2000
-
负责人:John David Roberts
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
-
批准号:--
-
项目类别:外国学者研究基金
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI Z
-
依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
-
批准号:W2433169
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI ZHANG
-
依托单位:
甲状腺激素调控线粒体turnover在肥胖型和非肥胖型NAFLD的发病机制研究
-
批准号:81800752
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:张晓文
-
依托单位:
AUF1对p16 mRNA turnover 的调控机制及其在细胞衰老过程中的意义
-
批准号:30973147
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2009
-
负责人:王文恭
-
依托单位: